e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Biology of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Targeting Tryptophan metabolism pathway as a therapeutic strategy for non-small cell lung cancer
E. Jin (Hangzhou, China), Y. Li (Hangzhou, China), X. Chen (durham, United States of America), S. Ma (Hangzhou, China)
Source:
International Congress 2019 – Biology of lung cancer
Session:
Biology of lung cancer
Session type:
Poster Discussion
Number:
3656
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Jin (Hangzhou, China), Y. Li (Hangzhou, China), X. Chen (durham, United States of America), S. Ma (Hangzhou, China). Targeting Tryptophan metabolism pathway as a therapeutic strategy for non-small cell lung cancer. 3656
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
Source: Eur Respir Rev 2014; 23: 79-91
Year: 2014
Targeted therapy in non-small cell lung cancer
Source: Breathe 2012; 8: 206-215
Year: 2012
Global screening of AKT/PI3K signaling molecules for non-small cell lung cancer and its prognosis
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Targeted therapies: detrimental treatment for nonsmall cell lung cancer without driver mutations
Source: Eur Respir J 2015; 46: 19-21
Year: 2015
Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm
Source: Eur Respir J, 55 (2) 1901907; 10.1183/13993003.01907-2019
Year: 2020
Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapy
Source: Eur Respir J, 53 (3) 1801562; 10.1183/13993003.01562-2018
Year: 2019
Enhanced FGFR signaling correlates with erlotinib/bevacizumab response in advanced non-squamous non-small cell lung cancer
Source: International Congress 2015 – Advances in the therapy of lung cancer
Year: 2015
XAGE-1b and p53: Potential targets for immunotherapy of non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Biological therapies in nonsmall cell lung cancer
Source: Eur Respir J , 49 (3) 1601520; DOI: 10.1183/13993003.01520-2016
Year: 2017
CDCA promotes non-small-cell lung cancer (NSCLC) migration by regulating Akt/Erk1/2 signaling pathways
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Year: 2019
Anticancer treatment for advanced non-small cell lung cancer
Source: Breathe 2011; 8: 124-133
Year: 2011
Role of carbohydrate metabolism abnormality in non-small cell lung cancer-related immunoparalysis
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
A non-small cell lung cancer modelling by endogenous κ-ras manipulation
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005
Identification of a novel crizotinib-sensitive BCL11A-ALK gene fusion in a nonsmall cell lung cancer patient
Source: Eur Respir J , 49 (4) 1602149; DOI: 10.1183/13993003.02149-2016
Year: 2017
Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015
Non-small cell lung cancer with single brain metastasis: the role of surgical treatment
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008
Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018
Alteration in clotting system in non-small cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 74s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept